Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Novocure Ltd Ord Sh (NVCR)

Novocure Ltd Ord Sh (NVCR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,367,598
  • Shares Outstanding, K 104,739
  • Annual Sales, $ 535,030 K
  • Annual Income, $ -58,350 K
  • 60-Month Beta 0.87
  • Price/Sales 15.03
  • Price/Cash Flow N/A
  • Price/Book 18.21
Trade NVCR with:

Options Overview Details

View History
  • Implied Volatility 57.83% ( -2.70%)
  • Historical Volatility 41.62%
  • IV Percentile 6%
  • IV Rank 14.69%
  • IV High 93.50% on 01/25/22
  • IV Low 51.69% on 08/17/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 1,044
  • Volume Avg (30-Day) 644
  • Put/Call OI Ratio 1.07
  • Today's Open Interest 34,807
  • Open Int (30-Day) 31,977

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.30
  • Number of Estimates 5
  • High Estimate -0.23
  • Low Estimate -0.39
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -130.77%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.01 +26.97%
on 07/29/22
84.98 -2.87%
on 08/11/22
+9.72 (+13.35%)
since 07/11/22
3-Month
56.39 +46.37%
on 06/16/22
85.53 -3.50%
on 06/03/22
+24.60 (+42.46%)
since 05/11/22
52-Week
56.39 +46.37%
on 06/16/22
144.28 -42.79%
on 08/12/21
-60.43 (-42.27%)
since 08/11/21

Most Recent Stories

More News
Novocure Hosts U.S. Sen. Maggie Hassan at Company’s Portsmouth Facility

On Tuesday, Aug. 9, U.S. Sen. Maggie Hassan (NH) joined members of Novocure’s leadership team to tour the company’s U.S. headquarters in Portsmouth, New Hampshire, and learn more about Novocure’s...

NVCR : 82.54 (+3.32%)
5 Top Stocks for August

It's not too late to snatch up some great stocks at good prices.

NVCR : 82.54 (+3.32%)
TTD : 71.59 (-3.57%)
DIS : 117.69 (+4.68%)
TMUS : 143.61 (-0.85%)
REXR : 66.44 (-0.54%)
Novocure (NVCR) Q2 2022 Earnings Call Transcript

NVCR earnings call for the period ending June 30, 2022.

NVCR : 82.54 (+3.32%)
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates

NovoCure (NVCR) delivered earnings and revenue surprises of -64.29% and 4.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NVCR : 82.54 (+3.32%)
UPH : 0.8900 (+28.82%)
Novocure Reports Second Quarter 2022 Financial Results

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended June 30, 2022. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer...

NVCR : 82.54 (+3.32%)
Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

Novocure today announced the recipients of the 4 th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program. The AACR-Novocure Grants for Tumor Treating Fields Research Program represents...

NVCR : 82.54 (+3.32%)
3 Beaten-Down Stocks That Could Soar in the Second Half of 2022

Each of these stocks is ready for a rebound.

AXSM : 45.32 (-6.29%)
MRVI : 26.78 (+1.52%)
NVCR : 82.54 (+3.32%)
3 Growth Stocks That Could Make You Richer in the Second Half of 2022

These stocks appear to have good chances of delivering solid gains by year-end.

NVCR : 82.54 (+3.32%)
AXSM : 45.32 (-6.29%)
CRLBF : 3.5800 (+1.70%)
Novocure to Report Second Quarter 2022 Financial Results

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the second quarter 2022 on Thursday, July 28, 2022, before the U.S. financial markets open. Novocure’s management will...

NVCR : 82.54 (+3.32%)
Strength Seen in NovoCure (NVCR): Can Its 8% Jump Turn into More Strength?

NovoCure (NVCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

NVCR : 82.54 (+3.32%)
MEDP : 178.60 (+1.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

See More

Key Turning Points

3rd Resistance Point 89.69
2nd Resistance Point 87.33
1st Resistance Point 84.94
Last Price 82.54
1st Support Level 80.19
2nd Support Level 77.83
3rd Support Level 75.44

See More

52-Week High 144.28
Fibonacci 61.8% 110.71
Fibonacci 50% 100.33
Fibonacci 38.2% 89.96
Last Price 82.54
52-Week Low 56.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar